June 25, 2026, post.   I understand there is a new gold-rush movement to accelerate the use of psychedelics in mental healthcare.   But beware of the identity and quality of your psychedelic used when you are in a hurry to get rich!  

Wrong identity or impure test materials can mean unreliable or misleading results.  Remember what the basis was for the so-called ‘ginseng-abase syndrome’?  Something labeled ‘ginseng’ from a  store!?   Or the MD declaring he could do acupuncture because he was used to  sticking needles in patients.

Now closer to home (our psychedelics) – just consider 1% LSD present in a dose of psilocybin for whatever reason; that would double the psychedelic effects because LSD is up to 200X stronger than psilocybin.  So, my colleagues, be careful!   Has any of our colleagues published research that shows this purity/identity issue of any commonly used or researched synthetic psychedelic, one way or another?

In the next post, I want to continue to connect the vicious cycle (VC) of drug therapy using synthetic chemicals with the persistent poor health of Americans, exploited or caused by the drug industry.   The only way to eliminate this VC is by government-owned healthcare as most truly democratic, educated, or civilized nations like Canada and the Scandinavian countries, whose multibillionaires pay taxes unlike ours who don’t pay any.

Leave a Reply

Your email address will not be published. Required fields are marked *